Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background We have previously demonstrated that in patients with chronic hepatitis C (CHC), iron depletion improves serum alanine aminotransferase (ALT) levels as well as hepatic oxidative DNA damage. However, it has not been determined whether continuation of iron depletion therapy for CHC favorably influences its progression to hepatocellular carcinoma (HCC).Methods We conducted a cohort study on biopsy-proven CHC patients with moderate or severe liver fibrosis who failed to respond to previous interferon (IFN) therapy or had conditions for which IFN is contradicted. Patients were divided into two groups: subjects in group A (n = 35) underwent weekly phlebotomy (200 g) until they reached a state of mild iron deficiency, followed by monthly maintenance phlebotomy for 44-144 months (median, 107 months), and they were advised to consume a low-iron diet (5-7 mg iron/day); group B (n = 40) comprised CHC patients who declined to receive iron depletion therapy.Results In group A, during the maintenance phase, serum ALT levels decreased to less than 60 IU/l in all patients and normalized (<40 IU/l) in 24 patients (69%), whereas in group B no spontaneous decrease in serum ALT occurred. Hepatocarcinogenesis rates in groups A and B were 5.7% and 17.5% at the end of the fifth year, and 8.6% and 39% in the tenth year, respectively. Multivariate analysis revealed that iron depletion therapy significantly lowered the risk of HCC (odds ratio, 0.57) compared with that of untreated patients (P = 0.0337).Conclusions Long-term iron depletion for CHC patients is a promising modality for lowering the risk of progression to HCC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phlebotomy has been applied in Japan to patients with chronic active hepatitis C16, 17, 28, 29 and polycythemia vera.30”
From Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats (2018) · cites this paper as [17]
In the citing paper
“In this context, iron removal indeed can reduce the risk of hepatic cancer,16, 17 and presumably of other cancers in humans.18”
From Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats (2018) · cites this paper as [17]
In the citing paper
“We have previously revealed that a close link exists between oxidative DNA damage induced by hepatic iron overload and hepatocarcinogenesis in patients with chronic hepatitis C (CHC).”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [39]
In the citing paper
“With a reduction in therapeutic iron, elevated hepatic ROS, evaluated by immunostaining 8‐oxodG, significantly decreased to almost normal levels with a concomitant improvement of hepatitis, followed by a lowered risk of the development of hepatocellular carcinoma (HCC) in patients with CHC.38, 39”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [39]
Citations
Cites
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
The Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860
The role of 8-hydroxyguanine in carcinogenesis
Floyd, R. A. (1990) · Carcinogenesis · doi:10.1093/carcin/11.9.1447 · Cited by 718
Oxidative damage and fibrogenesis
Poli, G., & Parola, M. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00327-9 · Cited by 478
Desmet, V. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00005-9 · Cited by 447
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Perni, R. B., Almquist, S. J., Byrn, R. A., Chandorkar, G., Chaturvedi, P. R., Courtney, L. F., Decker, C. J., Dinehart, K., Gates, C. A., Harbeson, S. L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.899-909.2006 · Cited by 386
Research works printed but not linked: 3
- SL Chen, 2006, Int J Med, 3, 47
- H Hayashi, 1994, Am J Gastroenterol, 89, 986
- J Kato, 2001, Cancer Res, 61, 8697
Cited by
Reactive Oxygen Species in Cancer: Current Findings and Future Directions
Nakamura, H., & Takada, K. (2021) · Cancer Science · doi:10.1111/cas.15068 · Cited by 1,027
Self-citationKudo, M., Izumi, N., Kokudo, N., Matsui, O., Sakamoto, M., Nakashima, O., Kojiro, M., Makuuchi, M., & for the HCC Expert Panel of Japan Society of Hepatology (2011) · Digestive Diseases · doi:10.1159/000327577 · Cited by 825
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
Role of iron in carcinogenesis: cancer as a ferrotoxic disease
Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
Metadata
- Authors
- Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., Takayama, T., & Niitsu, Y.
- Affiliations
- Sapporo Medical University (JP)
- ORCID
- Venue
- Journal of Gastroenterology
- Published
- 2007-10-15
- Volume
- 42
- Issue
- 10
- Pages
- 830-836
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2170760996
- Cited by
- 172
- References
- 22
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 9 · 2015: 7 · 2014: 16 · 2013: 13 · 2012: 19
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- chronic hepatitis C, hepatocellular carcinoma, phlebotomy, low-iron diet, iron deficiency, hepatocarcinogenesis, liver fibrosis, alanine aminotransferase
- MeSH terms
- Iron Deficiencies, Adult, Aged, Alanine Transaminase, Diet, Female, Follow-Up Studies, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Male, Middle Aged, Risk Factors, Cohort Studies, Multivariate Analysis, Phlebotomy, Iron, Dietary, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. https://app.cochat.ai/papers/10.1007/s00535-007-2095-z
- The paper
- Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., Takayama, T., & Niitsu, Y. (2007). Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. Journal of Gastroenterology. https://doi.org/10.1007/s00535-007-2095-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.